![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Dongkook Life Science Co. Ltd. Seoul Kr, based in South Korea, is a pharmaceutical company.
One of their significant offerings is Iopamidol, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 1999-090 - Rev 03
This Chemical Type CEP, issued on November 14, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1115 associated with this CEP further emphasizes